Morgan Stanley Haleon PLC Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Haleon PLC stock. As of the latest transaction made, Morgan Stanley holds 9,891,621 shares of HLN stock, worth $101 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,891,621
Previous 8,237,797
20.08%
Holding current value
$101 Million
Previous $87.2 Million
8.5%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding HLN
# of Institutions
663Shares Held
417MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.83 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$336 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$247 Million1.6% of portfolio
-
Sculptor Capital LP New York, NY8.89MShares$91 Million2.49% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA8.75MShares$89.6 Million0.17% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...